MedTrace Logo

Development and Evaluation of a Hormone Replacement Therapy Decision-Aid

NCT00012909 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2015-04-07

No results posted yet for this study

Summary

The decision regarding the use of post-menopausal estrogen hormone replacement therapy (HT) is complex because patients must balance the short and long-term risks and benefits. Information from new and important clinical trials must also be considered. The purpose of this research is to develop and evaluate the efficacy of a HT CD-ROM decision-aid in improving the decision making process for women considering the use of estrogen HT.

Conditions

Interventions

BEHAVIORAL

Hormone Replacement Therapy Decision-Aid

Sponsors & Collaborators

Principal Investigators

  • Marilyn M. Schapira, MD MPH · Clement J. Zablocki VA Medical Center, Milwaukee, WI

  • Arneda Van White, MD · Edward Hines Jr. VA Hospital, Hines, IL

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
74 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Completion
2004-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00012909 on ClinicalTrials.gov